CPT1A and cancer: A rate-limiting enzyme in the carnitine shuttle, CPT1A, has emerged as a key regulator of ferroptosis sensitivity in multiple cancer types [21], which is attributed to several mechanisms, including the decreased production of NADPH (a critical cofactor for glutathione regeneration), altered lipid composition, and increased mitochondrial ROS production [25].